Riskpilot← Back to searchSign inGet full accessVATVEDTKLINIKKEN AS
ASActiveOrg 896916262Nansens Gate 2B, 1707 SarpsborgMedical specialists activities · NACE 8622Est. 20116 employeesvatvedtklinikken.no
Revenue 2024
NOK 10,1M
+39% vs 2023
EBITDA margin
13.7%
+11% vs 2023
Equity ratio
66.0%
Financial strength
Net profit 2024
NOK 910K
+2% vs 2023
| Revenue | NOK 10,1M | +39% |
| EBITDA | NOK 1,4M | +11% |
| Net profit | NOK 910K | +2% |
| Total assets | NOK 3,7M | +45% |
| Equity | NOK 2,5M | +59% |
| Employees | 6 | — |
Legal name
VATVEDTKLINIKKEN AS
Org number
896916262
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
12. mai 2011
Share capital
NOK 100 000
Employees
6 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Legepraksis, informasjonsformidling, opplæringsvirksomhet og utleie av spesialisttjenester. Videre finansforvaltning, investeringer i eiendom samt alt som naturlig hører inn under disse virksomhetsområder.
Address
Nansens Gate 2B, 1707 Sarpsborg
Website
vatvedtklinikken.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1 598 | 4 474 | 5 782 | 5 982 | 5 778 | 6 007 | 6 429 | 7 151 | 6 473 | 6 599 | 7 213 | 7 234 | 7 235 | 10 081 |
| Staff expenses | −795 | −2 061 | −2 729 | −2 737 | −2 086 | −1 612 | −1 659 | −1 618 | −1 627 | −1 250 | −1 174 | −1 452 | −1 622 | −3 265 |
| EBITDA | 481 | 1 153 | 1 425 | 1 614 | 1 439 | 1 800 | 2 074 | 2 535 | 1 538 | 1 879 | 2 257 | 1 796 | 1 249 | 1 385 |
| Depreciation & amort. | −139 | −458 | −523 | −525 | −522 | −406 | −105 | −51 | −0 | −6 | −5 | −4 | −109 | −214 |
| EBIT | 342 | 695 | 902 | 1 089 | 916 | 1 395 | 1 968 | 2 484 | 1 538 | 1 873 | 2 252 | 1 792 | 1 141 | 1 171 |
| Net financials | 0 | 2 | −0 | 26 | 28 | 51 | 36 | 2 | 5 | −2 | 0 | 0 | −2 | −4 |
| Profit before tax | 342 | 696 | 901 | 1 115 | 944 | 1 445 | 2 004 | 2 486 | 1 543 | 1 871 | 2 253 | 1 792 | 1 138 | 1 168 |
| Tax | 94 | 198 | 255 | 308 | 262 | 369 | 487 | 569 | 342 | 411 | 496 | 394 | 250 | 258 |
| Net profit | 248 | 498 | 646 | 807 | 682 | 1 076 | 1 517 | 1 917 | 1 201 | 1 460 | 1 757 | 1 398 | 888 | 910 |
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2 570 | 3 235 | 3 051 | 2 719 | 2 866 | 2 944 | 2 861 | 3 799 | 3 935 | 4 538 | 5 349 | 6 845 | 2 563 | 3 719 |
| Equity | 348 | 327 | 173 | 907 | 902 | 579 | 1 096 | 2 013 | 2 102 | 3 562 | 4 257 | 5 654 | 1 543 | 2 453 |
| Long-term debt | 1 997 | 1 660 | 1 279 | 917 | 611 | 278 | 0 | 72 | 146 | 207 | 253 | 291 | 241 | 188 |
| Short-term debt | 224 | 1 248 | 1 598 | 895 | 1 352 | 2 088 | 1 765 | 1 714 | 1 687 | 769 | 839 | 900 | 779 | 1 078 |
| Total debt | 2 221 | 2 908 | 2 877 | 1 812 | 1 963 | 2 365 | 1 765 | 1 786 | 1 833 | 976 | 1 092 | 1 191 | 1 020 | 1 266 |
EBITDA margin
13.7%
This company
15.8%
Market median
-13% vs market
20112024
Equity ratio
66.0%
This company
38.2%
Market median
+73% vs market
20112024
Return on equity
37.1%
This company
18.4%
Market median
+102% vs market
20112024
Net profit margin
9.0%
This company
8.1%
Market median
+11% vs market
20112024
Asset turnover
2.71×
This company
1.12×
Market median
+142% vs market
20112024
Debt / equity
0.52×
This company
0.62×
Market median
+16% vs market
20112024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-04-26 – 2011-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AG Deputy Member | Deputy Member | 2011 | — | — |
KE Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Keag Holding As | Company | 100.0% | 100.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Keag Holding As
VATVEDTKLINIKKEN AS Board members of VATVEDTKLINIKKEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anne Gyro Karlsen | Deputy Member | 0 companies |
| Knut Eilert Karlsen | Chief Executive Officer | 0 companies |